Form 4 · PFE
Pfizer director James C. Smith reports an award of about 1,570 phantom stock units
James C. Smith, a Pfizer director, filed a Form 4 on Sep 29, 2026 at 2:25 PM ET reporting transactions on Sep 25, 2026.
The filing reports about 1,570 phantom stock units in a grant or award (code A).
Reporting person
- James C. Smith, director (as filed: SMITH JAMES C)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | A | Phantom Stock Units (derivative) | 1,570 | $28.67 | Acquired | 187,210 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Sep 29, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Pfizer company file → · More Pfizer filings
Disclosures
- Editor holdings in PFE
- The editor holds no position in Pfizer (PFE). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold PFE.